Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when THRM files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsGentherm raises FY2026 guidance, authorizes up to $400M buyback replacing up to $150M program
Filed July 23, 2026 · Period ending July 23, 2026 · ~1 min read
Key Changes
-
high
Board authorized new up to $400M three-year stock repurchase program through July 2029, replacing prior up to $150M program that had $110M remaining; signals confidence in cash generation.
Item 8.01 — Other Events verify on EDGAR → -
high
Raised FY2026 revenue guidance to $1.55B–$1.65B (from $1.5B–$1.6B), adjusted EBITDA to $185M–$200M (from $175M–$195M), and adjusted free cash flow to $85M–$100M (from $80M–$100M).
Exhibit 99.1 view on EDGAR → -
high
Q2 2026 revenue hit record $416.2M, up 11.0% year-over-year (9.5% constant currency); adjusted diluted EPS rose to $0.75 from $0.54; adjusted EBITDA margin compressed to 11.7% from 12.2%.
Exhibit 99.1 view on EDGAR → -
high
Completed key sign-to-close deliverables for planned Modine Performance Technologies combination; transaction remains on track to close by early Q4 2026.
Exhibit 99.1 view on EDGAR → -
medium
Acquired Innovative Medical Equipment (ThermaZone thermal therapy device) to expand medical thermal management portfolio and create cross-selling opportunities across healthcare channels.
Exhibit 99.1 view on EDGAR →
Summary
Gentherm reported strong Q2 2026 results and raised full-year guidance across revenue, profitability, and cash flow metrics. The company delivered record quarterly revenue of $416.2 million (up 11.0% year-over-year) driven by 9.8% constant-currency growth in Automotive, though adjusted EBITDA margin compressed 50 basis points to 11.7%.
Management's confidence in the trajectory led to upward revisions: revenue guidance now $1.55B–$1.65B (from $1.5B–$1.6B), adjusted EBITDA $185M–$200M (from $175M–$195M), and adjusted free cash flow $85M–$100M (from $80M–$100M).
The Board terminated the 2024 up to $150M buyback program (which had $110.1M remaining) and authorized a new up to $400M three-year repurchase program through July 2029—a nearly 4x increase in authorization that underscores management's view of cash generation capacity and capital allocation priorities. The company also completed key deliverables for its planned combination with Modine Performance Technologies, which remains on track to close by early Q4 2026. Separately, Gentherm acquired Innovative Medical Equipment to expand its medical thermal management portfolio, though Medical segment revenue declined 0.2% in Q2 on a constant-currency basis. The pending Modine transaction and execution of the enlarged buyback program are the near-term items to watch.
Section-by-Section Diff
Event · Item 7.01 — Regulation FD Disclosure
Gentherm scheduled a Q2 2026 earnings call for July 23, 2026 at 8:00 a.m. ET with supplemental materials posted online.
Added in current filing · verify on EDGAR →
On July 23, 2026 at 8:00 a.m. Eastern Time, the Company will host a conference call to discuss the second quarter of 2026 results and provide an update on its full year 2026 guidance.
Gentherm announced a conference call scheduled for July 23, 2026 at 8:00 a.m. Eastern Time to discuss second quarter 2026 results and provide an update on full year 2026 guidance. Supplemental materials for the call are available on the company's investor relations website.
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Effective as of the Effective Date, the Board authorized a new stock repurchase program (the “2026 Stock Repurchase Program”), pursuant to which the Company is authorized to repurchase up to $400 million of its issued and outstanding common stock over a three-year period, expiring July 27, 2029.
The Board authorized a new $400 million stock repurchase program running through July 27, 2029. This substantially increases the company's capital return capacity compared to the terminated program's remaining authorization and signals confidence in the business and cash generation.
Added in current filing · verify on EDGAR →
Repurchases under the 2026 Stock Repurchase Program may be made, from time to time, in amounts and at prices the Company deems appropriate, subject to alternative uses of capital and prevailing market conditions, applicable legal requirements, debt covenants and other contractual restrictions, and other considerations. Under the authorization, any such repurchases may be executed using open market purchases, privately negotiated agreements, accelerated share repurchase programs, transactions in accordance with Rule 10b5-1 under the Exchange Act, or other transactions, and may be funded from cash on hand, available borrowings or proceeds from future equity or debt offerings.
The program permits flexible execution through open market purchases, negotiated transactions, accelerated share repurchases, or Rule 10b5-1 plans, funded from cash, borrowings, or future capital raises. Timing and amounts remain at management's discretion based on market conditions and alternative capital uses.
Event · Exhibit 99.1
Gentherm reported Q2 2026 record revenue of $416M, raised full-year guidance, and announced a new up to $400M stock repurchase program.
Added in current filing · view on EDGAR →
Product revenues of $416.2 million increased 11.0% from $375.1 million in the prior year. Excluding the impact of foreign currency translation, product revenues increased 9.5%, with Automotive increasing 9.8% and Medical decreasing 0.2%.
Gentherm delivered record quarterly revenue of $416.2 million in Q2 2026, up 11.0% year-over-year (9.5% excluding foreign currency effects). Automotive revenue grew 9.8% while Medical revenue declined 0.2% on a constant-currency basis. Adjusted EBITDA was $48.8 million (11.7% margin) versus $45.9 million (12.2% margin) in the prior year. Adjusted diluted EPS rose to $0.75 from $0.54.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jul 24, 2026 · How we verify